XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://biotechstocks.com/why-amicus-therapeutics-inc-nasdaqfold-is-in-focus/20%Monthly2018-02-28 10:46
https://biotechstocks.com/corcept-therapeutics-incorporated-nasdaqcort-posts-2017-financial-report/20%Monthly2018-02-28 10:44
https://biotechstocks.com/axovant-sciences-ltd-nasdaqaxon-reports-changes-to-management-team/20%Monthly2018-02-28 10:47
https://biotechstocks.com/pluristem-therapeutics-inc-psti-plx-r18-improves-hematopoietic-transplantation/20%Monthly2018-02-28 13:40
https://biotechstocks.com/sangamo-therapeutics-inc-nasdaqsgmo-posts-fourth-quarter-2017-financial-report/20%Monthly2018-02-27 09:26
https://biotechstocks.com/why-opko-health-inc-nasdaqopk-is-in-focus/20%Monthly2018-02-27 09:24
https://biotechstocks.com/amgen-inc-nasdaqamgn-gets-positive-opinion-expanding-xgeva-use/20%Monthly2018-02-27 09:21
https://biotechstocks.com/what-you-should-know-about-juno-therapeutics-inc-nasdaqjuno/20%Monthly2018-02-26 09:47
https://biotechstocks.com/novavax-inc-nasdaqnvax-extends-its-decline/20%Monthly2018-02-26 09:47
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-reports-senior-management-change/20%Monthly2018-02-26 09:47
https://biotechstocks.com/insys-therapeutics-inc-insy-to-report-fourth-quarter-2017-results-on-march-8/20%Monthly2018-02-23 16:27
https://biotechstocks.com/amgen-amgn-receives-positive-opinion-expanding-use-of-xgeva-denosumab/20%Monthly2018-02-23 16:24
https://biotechstocks.com/why-to-keep-eye-on-gilead-sciences-inc-nasdaqgild/20%Monthly2018-02-23 09:51
https://biotechstocks.com/what-is-the-buzz-surrounding-sorrento-therapeutics-inc-nasdaqsrne/20%Monthly2018-02-23 09:49
https://biotechstocks.com/immunogen-inc-nasdaqimgn-updates-on-pipeline-progress/20%Monthly2018-02-23 09:48
https://biotechstocks.com/kite-a-gilead-company-gild-and-sangamo-therapeutics-inc-sgmo-announce-collaboration/20%Monthly2018-02-22 13:26
https://biotechstocks.com/agenus-inc-nasdaqagen-reports-combination-clinical-studies-of-its-anti-ctla4-and-anti-pd1/20%Monthly2018-02-22 15:32
https://biotechstocks.com/riot-blockchain-inc-nasdaqriot-issues-shareholder-update/20%Monthly2018-02-22 07:01
https://biotechstocks.com/cormedix-inc-nyseamericancrmd-achieves-target-count-of-events-in-its-lock-it-100-trial-of-neutrolin-for-interim-efficacy-analysis/20%Monthly2018-02-22 07:00
https://biotechstocks.com/aimmune-therapeutics-inc-nasdaqaimt-phase-3-palisade-study-of-ar101-attains-primary-endpoint-in-subjects-with-peanut-allergy/20%Monthly2018-02-21 06:57
https://biotechstocks.com/jaguar-health-inc-nasdaqjagx-issues-updates-regarding-educational-commercial-and-product-development-programs/20%Monthly2018-02-21 06:56
https://biotechstocks.com/achieve-life-sciences-inc-nasdaqachv-issues-preliminary-report-from-cytisine-phase-12-multi-dose-pkpd-clinical-trial/20%Monthly2018-02-21 06:55
https://biotechstocks.com/celgene-corporation-nasdaqcelg-relief-trial-show-positive-results-for-dermatology-drug-otezla/20%Monthly2018-02-20 08:42
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-wins-2-54-billion-reversal-of-patent-verdict/20%Monthly2018-02-20 08:40
https://biotechstocks.com/riot-blockchain-inc-nasdaqriot-shares-tumble-by-34-after-exposure-of-rebranding-manipulation-shareholders-file-lawsuit/20%Monthly2018-02-20 08:38
https://biotechstocks.com/biogen-increases-sample-size-for-alzheimers-phase-3-stock-takes-a-dip/20%Monthly2018-02-19 15:34
https://biotechstocks.com/vertexs-new-drug-tests-positive-on-its-second-phase-2-test/20%Monthly2018-02-19 15:28
https://biotechstocks.com/puration-inc-otcmktspura-to-unveil-innovative-everx-cbd-infused-sports-nutrition-products-at-the-upcoming-arnold-schwarzenegger-sports-festival/20%Monthly2018-02-16 14:57
https://biotechstocks.com/golden-leaf-holdings-ltd-otcmktsgldff-ropes-in-craig-eastwood-as-cfo/20%Monthly2018-02-16 14:55
https://biotechstocks.com/leafbuyer-technologies-inc-otcmktslbuy-to-thrive-in-the-california-recreational-cannabis-market/20%Monthly2018-02-16 14:52
https://biotechstocks.com/gt-biopharma-gtbp-otcqb-announces-appointment-of-shawn-m-cross-as-chairman-and-chief-executive-officer/20%Monthly2018-06-06 16:42
https://biotechstocks.com/will-gene-editing-help-rid-the-world-of-hiv/20%Monthly2018-02-14 20:42
https://biotechstocks.com/astellas-offers-over-100-million-for-universal-donor-cell-company/20%Monthly2018-02-14 20:31
https://biotechstocks.com/celg-announces-additional-5-billion-share-repurchase-authorization/20%Monthly2018-02-14 15:24
https://biotechstocks.com/corbus-pharmaceuticals-holdings-inc-crbp-to-present-at-the-2018-rbc-capital-markets-global-healthcare-conference/20%Monthly2018-02-14 16:27
https://biotechstocks.com/bti-has-decided-to-run-trials-for-alzheimers-and-cancer-treatments/20%Monthly2018-02-13 21:03
https://biotechstocks.com/mpi-research-has-been-acquired-by-charles-river-for-800-million/20%Monthly2018-02-13 21:01
https://biotechstocks.com/advaxis-inc-adxs-submits-conditional-marketing-authorization-application-for-axalimogene-filolisbac/20%Monthly2018-02-13 14:07
https://biotechstocks.com/gt-biopharma-inc-gtbp-announces-dr-jeffrey-miller-renowned-nk-cell-cancer-specialist-will-present-at-cell-therapy-symposia/20%Monthly2018-06-06 16:43
https://biotechstocks.com/sanofi-pulls-immunogen-cancer-drug-from-clinical-pipeline/20%Monthly2018-02-12 21:04
https://biotechstocks.com/can-new-technology-help-biopharma-enhance-the-returns-on-rd/20%Monthly2018-02-12 20:41
https://biotechstocks.com/the-best-biotech-stocks-of-this-year/20%Monthly2018-02-09 21:09
https://biotechstocks.com/madrigal-claims-to-solve-genetic-cholesterol-disorders-with-drug-nash/20%Monthly2018-02-09 21:08
https://biotechstocks.com/fda-provides-new-warnings-for-liver-disease-drugs/20%Monthly2018-02-07 20:47
https://biotechstocks.com/do-all-lung-cancer-treatment-have-the-same-medical-value/20%Monthly2018-02-07 20:29
https://biotechstocks.com/success-for-allergan-cgrp-drug-during-phase-3-migraine-trial/20%Monthly2018-02-06 20:54
https://biotechstocks.com/astrazeneca-focuses-on-500m-buyout/20%Monthly2018-02-06 20:49
https://biotechstocks.com/can-breast-cancer-treatments-cause-heart-issues/20%Monthly2018-02-05 20:44
https://biotechstocks.com/scientist-have-developed-a-blood-test-that-catches-early-signs-of-alzheimers/20%Monthly2018-02-05 20:27
https://biotechstocks.com/conatus-pharmaceuticals-inc-cnat-to-highlight-anticipated-clinical-data-readouts-and-strategic-initiatives/20%Monthly2018-02-05 15:03
https://biotechstocks.com/will-this-new-treatment-help-stop-hair-loss-for-cancer-patients/20%Monthly2018-02-02 20:17
https://biotechstocks.com/medical-break-throughs-in-2018/20%Monthly2018-02-01 21:04